Dr Reddy's enters Dow Jones Indices

Company recognised for its corporate sustainability leadership, is sole pharma firm in index of emerging markets

Dr Reddy's Laboratories has been listed as an index component of the Dow Jones Sustainability Indices (DJSI) 2016 in the pharmaceuticals, biotechnology and life sciences industry group.

“The company has been recognised for its corporate sustainability leadership and is the only pharmaceutical company on the index of emerging markets,” Dr Reddy's said in a BSE filing.

The listing was based on 22 criteria, with Dr Reddy's receiving high scores on product quality and recall management, environmental reporting, corporate citizenship and philanthropy, the company added.

G V Prasad, co-chairman and CEO of Dr Reddy's said: “Over the years, Dr Reddy's has evolved into a global organisation built on the foundation of responsible business practices. This has earned us the trust and respect of all the stake-holders we serve. I see our inclusion in the Dow Jones Sustainability Indices as another validation of our commitment to sustainability in all aspects of our business.”

The Dow Jones Sustainability Indices is a leading global benchmark for corporate sustainability.

DJSI tracks leading sustainability-driven companies based on the analysis of financially relevant environmental, social and governance factors.